Scid mice inoculated with HepG2/SerpinB3 cells showed significantly lower tumor growth, with weight and volume of tumor masses at sacrifice 5 and 6 times lower, respectively, than those detected in mice injected with HepG2/control cells (Figure 7A–C). This evidence concerns the gene SERPINB3 and neoplasm.